Comparison 9. Cholinesterase inhibitor vs placebo (number of fallers).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
9.1 Number of fallers	3	249	Risk Ratio (IV, Fixed, 95% CI)	1.01 [0.90, 1.14]
9.2 Number of fallers ‐ subgrouped by medication	3		Risk Ratio (IV, Random, 95% CI)	0.95 [0.70, 1.28]
9.2.1 Rivastigmine vs placebo	2		Risk Ratio (IV, Random, 95% CI)	0.61 [0.20, 1.90]
9.2.2 Donepezil vs placebo	1		Risk Ratio (IV, Random, 95% CI)	1.13 [0.90, 1.40]